Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease

被引:66
|
作者
Du, Xi-Xun [1 ]
Xu, Hua-Min [1 ]
Jiang, Hong [1 ]
Song, Ning [1 ]
Wang, Jun [1 ]
Xie, Jun-Xia [1 ]
机构
[1] Qingdao Univ, Coll Med, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao 266071, Peoples R China
基金
中国国家自然科学基金;
关键词
6-hydroxydopamine; curcumin; Parkinson's disease; dopaminergic neurons; iron; METAL TRANSPORTER 1; SUBSTANTIA-NIGRA; ANIMAL-MODELS; ANTIOXIDANT; CELLS; DEGENERATION; FLAVONOIDS; CADMIUM; BRAIN; MPTP;
D O I
10.1007/s12264-012-1238-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Curcumin is a plant polyphenolic compound and a major component of spice turmeric (Curcuma longa). It has been reported to possess free radical-scavenging, iron-chelating, and anti-inflammatory properties in different tissues. Our previous study showed that curcumin protects MES23.5 dopaminergic cells from 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in vitro. The present study aimed to explore this neuroprotective effect in the 6-OHDAlesioned rat model of Parkinson's disease in vivo. Rats were given intragastric curcumin for 24 days. 6-OHDA lesioning was conducted on day 4 of curcumin treatment. Dopamine content was assessed by high-performance liquid chromatography with electrochemical detection, tyrosine hydroxylase (TH)-containing neurons by immunohistochemistry, and iron-containing cells by Perls' iron staining. The dopamine content in the striatum and the number of TH-immunoreactive neurons decreased after 6-OHDA treatment. Curcumin pretreatment reversed these changes. Further studies demonstrated that 6-OHDA treatment increased the number of iron-staining cells, which was dramatically decreased by curcumin pretreatment. The protective effects of curcumin against 6-OHDA may be attributable to the ironchelating activity of curcumin to suppress the iron-induced degeneration of nigral dopaminergic neurons.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 50 条
  • [31] Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat
    Martí, MJ
    Saura, J
    Burke, RE
    Jackson-Lewis, V
    Jiménez, A
    Bonastre, M
    Tolosa, E
    BRAIN RESEARCH, 2002, 958 (01) : 185 - 191
  • [32] The beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson's disease
    Abuthawabeh, Rasha
    Abuirmeileh, Amjad N.
    Alzoubi, Karem H.
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2020, 38 (05) : 369 - 373
  • [33] Pramipexole protects dopaminergic neurons through paraplegin against 6-hydroxydopamine
    Kim, Mun Ki
    Park, Hyeon Soo
    Cho, Jea Hyeon
    Kim, Gon Sup
    Won, Chungkil
    NEUROREPORT, 2015, 26 (02) : 74 - 80
  • [34] Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion
    Zuch, CL
    Nordstroem, VK
    Briedrick, LA
    Hoernig, GR
    Granholm, AC
    Bickford, PC
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 427 (03) : 440 - 454
  • [36] 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease
    Shi, Limin
    Jia, Lu
    Wang, Yiyun
    Xiu, Minxia
    Xie, Junxia
    NEUROCHEMICAL RESEARCH, 2023, 48 (06) : 1707 - 1715
  • [37] 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson’s Disease
    Limin Shi
    Lu Jia
    Yiyun Wang
    Minxia Xiu
    Junxia Xie
    Neurochemical Research, 2023, 48 : 1707 - 1715
  • [38] Extensive exploration of a novel rat model of Parkinson's disease using partial 6-hydroxydopamine lesion of dopaminergic neurons suggests new therapeutic approaches
    Vetel, Steven
    Serriere, Sophie
    Vercouillie, Johnny
    Vergote, Jackie
    Chicheri, Gabrielle
    Deloye, Jean-Bernard
    Dolle, Frederic
    Bodard, Sylvie
    Tronel, Claire
    Nadal-Desbarats, Lydie
    Lefevre, Antoine
    Emond, Patrick
    Chalon, Sylvie
    SYNAPSE, 2019, 73 (03)
  • [39] Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease
    Sadeghian, M.
    Mullali, G.
    Pocock, J. M.
    Piers, T.
    Roach, A.
    Smith, K. J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2016, 42 (05) : 423 - 435
  • [40] Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson’s Disease
    Sang J. Na
    Anthony G. DiLella
    Edward V. Lis
    Keith Jones
    David M. Levine
    David J. Stone
    J. F. Hess
    Neurochemical Research, 2010, 35 : 761 - 772